People

Markus Hosang

Markus Hosang joined BioMedPartners in 2004 following venture investing at MPM Capital and approximately two decades of pharmaceutical research leadership at Roche. He studied biochemistry at ETH Zurich and undertook postgraduate training at Stanford and the University of Washington. These are institutional manager affiliations; no personal portfolio investment is inferred.

Roles

BioMedPartners

Managing Partner

Current
BioMedPartners

Vice-Chair, statutory board (2021 official appointment confirmation)

Current